NeuroQuant is an AI-assisted analysis that measures brain structure volume and uses that data in comparison to a healthy population to determine risk or status of a number of brain-related ailments. In certain disease processes, brain structures can undergo physical changes which can be non-determinant by the naked eye, but rather easily quantified when using NeuroQuant technology. Using a patient's previous NeuroQuant report(s), changes can be tracked over time to show increased degeneration, stability, or to track improvements as positive results from using various therapies.
There are a number of NeuroQuant reports, providing volumetric detail as it relates to dementia, MS, trauma, seizures, growth, and other pathologies. Specific areas of the brain can be targeted for reporting and custom reports can be created as needed. Ages 3-100 can benefit from NeuroQuant technology. While most young children cannot undergo out-patient MRI exams (due to sedation requirements), older children and young adults' exams may yield valuable information regarding brain development. In the older population, it is common to use NeuroQuant reporting to assess white matter hyperintensities for Alzheimer's disease.
NeuroQuant reporting requires 2 additional scans to a routine MRI exam. Those scans are sent to NeuroQuant labs, where they assessment is done, and the quantification report is returned to the imaging facility to be included in the routine MRI report. Some government and commercial insurances may pay for the NeuroQuant report.
When a routine brain MRI is uable to visually determine early disease processes in a healthy adult, NeuroQuant quantification reporting could detect volumetric abnormalities, or the report could provide a baseline for future imaging comparison.
NeuroQuant and Southern Radiology Specialists: We're both on board for added-value MRI brain scans.
